Iva Healthcare Pvt. Ltd.
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Formistar-GV Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Formistar-GV Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Formistar-GV Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Formistar-GV Tablet.
Formistar-GV Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Formistar-GV Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Formistar-GV Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Formistar-GV Tablet contains Glimepiride, Metformin, and Voglibose. This medication is used to treat Type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken alongside proper diet and exercise. Glimepiride works by increasing insulin release from the pancreas. Metformin reduces glucose production by the liver and improves insulin sensitivity. Voglibose lowers postprandial (after meal) glucose levels by inhibiting alpha-glucosidases. This combination is not indicated for Type 1 DM treatment.
Common side effects associated with Formistar-GV Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Individuals with known allergy to any of the medicine's components or excipients should avoid Formistar-GV Tablet. In addition, use is avoided in patients with moderate to severe kidney disease and those with inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Formistar-GV Tablet with alcohol is not recommended. It may lower blood sugar levels and increase the risk of lactic acidosis.
Yes, Formistar-GV Tablet can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, a fast heart rate, and feeling anxious or shaky. This is more likely to occur when missing meals, drinking alcohol, over-exercising, or taking other antidiabetic medications simultaneously. Regular monitoring of blood glucose levels is essential. Ensure you always have glucose tablets, honey, or fruit juice readily available.
Store Formistar-GV Tablet in its original package or container, tightly closed. Refer to the instructions provided on the packaging for proper storage guidance. Do not consume leftover medicine; dispose of it responsibly, ensuring that pets, children, and others do not have access to it.